Tilray | TRLY - Passivo Circulante





Passivo Circulante Alterar Data
Acasti Pharma USD 1.28M 39K 2025-12
Akebia Therapeutics USD 160.86M 13.02M 2026-06
Alaunos Therapeutics USD 595K 218K 2026-03
Aurora Cannabis CAD 66.93M 79M 2026-03
Avita Medical AUD 62.68M 77K 2025-12
Canopy Growth CAD 158.44M 60.15M 2026-03
Cronos Group USD 56.36M 13.94M 2026-06
Dianthus Therapeutics USD 34.39M 3.89M 2026-06
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
IQVIA Holdings USD 8.82B 486M 2026-06
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Moderna USD 2.53B 139M 2026-06
Organigram Holdings CAD 88.74M 5.31M 2026-03
Organon & Co USD 2.5B 110M 2026-03
Revvity USD 1.28B 37.71M 2026-06
Tectonic Therapeutic USD 12.96M 3.29M 2026-03
Tilray USD 259.32M 8.32M 2025-09
Viatris USD 6.35B 464.5M 2026-06
Xeris Pharmaceuticals USD 189.57M 70.97M 2026-06
Zealand Pharma A/S 404M 260.96M 2026-03